Wenbing Dai, PhD, Associate Professor
Tel/Fax：010-82805724
Email：daiwb@bjmu.edu.cn
Got his bachelor degree from Department of Pharmaceutics, College of Pharmacy, Wuhan University in 2003; Got his master degree from Department of Pharmaceutics, College of Pharmacy, Wuhan University in 2006；Got his doctor degree from Department of Pharmaceutics, School of Pharmaceutical Science, Peking University in 2009；Engaged in his postdoctoral fellow in School of Basic Medical Sciences, Peking University from 2009 to 2012; Has been working in Department of Pharmaceutics, School of Pharmaceutical Science, Peking University since 2012.
He has host 2 projects of NSFC and 2 projects National Major Science Technology Projects. Has published more than 10 articles as first author or corresponding author and achieved 7 patents including 1 US patent.
Research Interesting：
1. Tumor targeted drug delivery based on tumor microenvironment priming.
2. Combination antitumor therapy.
3. Bench-to-bedside translation of nanomedicine of poorly soluble drugs.；
Selected Publications：
1. Wenbing Dai, Xiaoyou Wang, Ge Song, Tongzhou Liu, Bing He, Hua Zhang, Xueqing Wang, Qiang Zhang*. Combination antitumor therapy with targeted dual-nanomedicines. Adv Drug Deliv Rev . 2017, 115, 23-45.
2. Binlong Chen, Wenbing Dai*, Bing He, Hua Zhang, Xueqing Wang, Yiguang Wang, Qiang Zhang*. Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment. Theranostics . 2017, 7(3): 538-58.
3. Wenbing Dai#, Fang Yang#, Ling Ma, Yuchen Fan, Bing He, Qihua He, Xueqing Wang, Hua Zhang, Qiang Zhang*. Combined mTOR inhibitor rapamycin and doxorubicin-loaded cyclic octapeptide modified liposomes for targeting integrin α3 in triple-negative breast cancer. Biomaterials , 2014, 35(20):5347-5358.
4. Binlong Chen#, Wenbing Dai#*, Dong Mei, Tongzhou Liu, Suxin Li, Bo He, Bing He, Lan Yuan, Hua Zhang, Xueqing Wang, Qiang Zhang*. Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system. J Control Release . 2016, 241(10): 68-80.
5. Zhiqiang Lin, Dong Mei, Meiwan Chen, Yitao Wang, Xianhui Chen, Zhaoyang Wang,Bing He, Hua Zhang, Xueqing Wang, Wenbing Dai*, Yuxin Yin*, Qiang Zhang*. A comparative study of thermo-sensitive hydrogels with water-insoluble paclitaxel in molecule, nanocrystal and microcrystal dispersions. Nanoscale . 2015, 7(36): 14838-47.
6. Binlong Chen, Zhaoyang Wang, Jing Sun, Qin Song, Bing He, Hua Zhang, Xueqing Wang, Wenbing Dai*, Qiang Zhang*. A tenascin C targeted nanoliposome with navitoclax for specifically eradicating of cancer-associated fibroblasts. Nanomedicine . 2016, 12(1): 131-41.
Other publications please refer to my ORCID: http://orcid.org/0000-0002-4114-4022
